Octreotide
A potent, long-acting synthetic SOMATOSTATIN octapeptide analog that inhibits secretion of GROWTH HORMONE and is used to treat hormone-secreting tumors; DIABETES MELLITUS; HYPOTENSION, ORTHOSTATIC; HYPERINSULINISM; hypergastrinemia; and small bowel fistula.
Year introduced: 1989
PubMed search builder options
Subheadings:
Tree Number(s): D04.345.566.650, D12.644.641.650
MeSH Unique ID: D015282
Registry Number: RWM8CCW8GP
Entry Terms:
- Sandostatine
- Sandostatin
- Octreotide Acetate
- Octreotide Acetate Salt
- SMS 201-995
- SMS 201995
- SMS 201 995
- Compound 201-995
- Compound 201995
- Compound 201 995
- SAN 201-995
- SAN 201995
- SAN 201 995
- Sandoz 201-995
- Sandoz 201995
- Sandoz 201 995
- SM 201-995
- SM 201995
- SM 201 995
Previous Indexing:
Pharmacologic Action: